Soleno earnings release
WebSoleno Therapeutics, Inc. Common Stock (SLNO) ... Press Releases Live; Analyst Research Live; Dividend History; ... Price/Earnings Ratio is a widely used stock evaluation measure. WebAug 10, 2024 · Soleno intends to meet with regulatory authorities later this year to determine next steps Closed public offering of common stock in June 2024, with net proceeds of approximately $53.7 million ...
Soleno earnings release
Did you know?
WebAug 10, 2024 · June 30, 2024 December 31, 2024 Assets (Unaudited) Current assets Cash and cash equivalents $ 24,065 $ 21,304 Prepaid expenses and other current assets WebJul 27, 2024 · Soleno Therapeutics, Inc. SLNO will provide updates on its pipeline candidates when it releases second-quarter 2024 results. The company has a mixed track record, …
WebJan 26, 2024 · Diazoxide Choline Controlled-Release (DCCR) Learn More. ... March 28, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical … WebMar 21, 2024 · Soleno Therapeutics Inc (SLNO) SEC Filing 8-K Material Event for the period ending Tuesday, March 21, 2024
WebCompany’s earnings for a period net of operating costs, taxes, and interest. -5.49M. -93.99%. Net profit margin. Measures how much net income or profit is generated as a percentage … WebAug 10, 2024 · Soleno Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results REDWOOD CITY, Calif., August 10, 2024 - Soleno Therapeutics, Inc. …
WebMar 21, 2024 · REDWOOD CITY, Calif., March 21, 2024 (GLOBE NEWSWIRE) — Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company …
WebJul 27, 2024 · We expect Soleno (SLNO) to provide its clinical program updates when its releases second-quarter 2024 results. Soleno (SLNO) to report Q2 Earnings: What's in the … cincinnati holiday events 2022WebView the latest Soleno Therapeutics Inc. (SLNO) stock price, news, historical charts, analyst ratings and financial information from WSJ. dhs marketwatchWebApr 10, 2024 · According to the issued ratings of 1 analysts in the last year, the consensus rating for Soleno Therapeutics stock is Buy based on the current 1 buy rating for SLNO. … dhs market research guideWebMar 21, 2024 · Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare … cincinnatiholidaymarket.com vendorsWebNov 9, 2024 · Soleno Therapeutics (SLNO) reported a 3rd Quarter September 2024 loss of $0.76 per share on revenue of $0.0 million. ... Earnings Release. Soleno Therapeutics … cincinnati holiday pops 2021WebSoleno Therapeutics Inc. balance sheet, income statement, cash flow, earnings & estimates, ratio and margins. View SLNO financial statements in full. dhs marshalltownWebApr 6, 2024 · Earnings Calendar; Market ... investor presentations, and featured press releases from company/university websites and ... Diazoxide Choline Controlled-Release (DCCR): Soleno Therapeutics Inc ... dhs maritime operations coordination plan